Previous 10 | Next 10 |
The NZS Capital Growth Equity strategy was down 23.44% net of fees in the second quarter of 2022. We believe companies that maximize non-zero-sum outcomes for all of their constituents, including employees, customers, suppliers, society, and the environment, will also maximize long-te...
Danaher is a Dividend Challenger with 8 consecutive years of dividend growth. Shares currently yield 0.39%. Danaher is aggressive with M&A announcing 10 acquisitions totaling more than $10 B in 2021. Danaher uses the M&A strategy to grow their reach within an industry...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. From 1/2/2016 to date investing in all 50 stocks, equally weighted, would have produced a total return of 69.6%, an...
Danaher Announces Appointment of Feroz Dewan to Danaher Board PR Newswire WASHINGTON , June 29, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Feroz Dewan to its Board of Directors and to the Board's Science...
For investors who have been waiting to buy shares in Agilent, this is probably a good time to buy at least a starter position. For the last couple of years, Agilent had traded above what fundamentals justified, and now finally shares are priced to deliver very decent 8-9% returns. ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Danaher Schedules Second Quarter 2022 Earnings Conference Call PR Newswire WASHINGTON , June 21, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Th...
A recession is 74% priced into stocks and there is a remote chance economic conditions could push the S&P 500 (SP500) (NYSEARCA:SPY) more than 1,000 points lower, Societe Generale says. Fair value of the S&P based on earnings remains at 3,850, but a couple more dominoes need to fall b...
KKR (NYSE:KKR) will work with Andrew Silvernail, former chairman and CEO of Madison Industries and IDEX Corp., to pursue acquisitions across a broad range of sectors, including industrials, health care, and consumer products. Silvernail will work with KKR (KKR) as an executive adviser to eval...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...